influenza
DESCRIPTION
Therapeutics of the fluTRANSCRIPT
![Page 1: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/1.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h
Influenza
Anas Bahnassi PhD
Pharmacotherapy of Infectious Diseases
Anas Bahnassi 2014
A Case-Based Approach
![Page 2: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/2.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h Introduction
• Influenza – An acute viral illness of the respiratory tract
caused by influenza A &B virus.
– Influenza-like illness is defined as an acute onset of respiratory illness with fever, cough, and one or more of the followings: • Sore throat.
• Arthralgia.
• Myalgia.
• Prostration.
Anas Bahnassi 2014
• Gastrointestinal symptoms may be present in children <5yrs.
• Fever may not show in children <5yrs or eldery >65yrs.
![Page 3: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/3.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h
Prevention Goals of Therapy
• Prevent influenza illness from occurring, especially in individuals at high risk of developing serious influenza-related symptoms.
• Decrease influenza-related hospitalizations and deaths.
Anas Bahnassi 2014
![Page 4: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/4.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h Investigations:
• History:
– With particular attention to symptoms and onset of symptoms, the key to appropriate use antiviral agents:
• When flu is circulating in the community, abrupt onset of fever ≥38.5ºC, and dry cough is likely to be the flu. Value of these symptoms is less in the very young and elderly.
• Young children may present with either nonsymptomatic febrile illness or with a respiratory illness resembling croup, bronchitis, broncholitis.
• Fever may not be prominent in elderly, if flu is circulating: suspect the flu with ≥ 2 symptoms: Sore throat, arthralgia, myalgia, or prostration.
Anas Bahnassi 2014
![Page 5: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/5.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h Investigations:
• Laboratory Testing: – Beyond formal surveillance programs, widespread
laboratory testing in the community is not necessarily or practical.
– As a general rule, nasopharyngeal swabs from ill long-term residents should be sent for lab test if ≥2 or more cases of ILI in ≤72 hrs.
– To decrease the potential of false negative results, swabs are best collected within 24hr of symptom onset and no later than 48 hrs.
Anas Bahnassi 2014
![Page 6: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/6.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h
Prevention Choices Nonpharmacologic
• Wash hands often, use sensitizers.
• Cough/sneeze into tissues and throw used tissues in garbage, use sleeve if tissues are not available.
• Stay home.
Pharmacologic
• Flu Vaccine
Anas Bahnassi 2014
![Page 7: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/7.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h Who should receive the flu vaccine?
• Patients at high risk for influenza-related complications: – Chronic cardiac or respiratory disorder. – Residents of nursing homes. – >65 yrs old. – Patients of DM, Cancer, Immunodeficiency,
Immunosuppression, Renal disease, Anemia, hemoglobinopathies, Chronic ASA therapy.
• Persons able of transmitting influenza to high risk patients: – Healthcare workers. – People with direct contact to high risk patients. – Childcare workers.
• Others: – People who provide essential community services. (police, fire..)
Anas Bahnassi 2014
![Page 8: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/8.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h
Criteria for prophylactic use of antiviral agents:
• Administer to all residents of a LTC facility who are not currently ill.
• Duration of prophylaxis is 8 days after the onset of symptoms of the last case.
• Administer for the duration of outbreak to healthcare provider in the LTC facility who refuse immunization.
• Continue prophylaxis to high risk patients for the duration of the outbreak when
Anas Bahnassi 2014
![Page 9: Influenza](https://reader037.vdocuments.site/reader037/viewer/2022100602/5584777fd8b42a6b4d8b50ba/html5/thumbnails/9.jpg)
Ph
arm
aco
ther
apy
of
Infe
ctio
us
Dis
eas
es
A C
ase
-Bas
ed A
pp
roac
h Pharmacotherapy:
Infectious Diseases:
Anas Bahnassi PhD
http://www.twitter.com/abpharm
http://www.facebook.com/pharmaprof
http://www.linkedin.com/in/abahnassi Anas Bahnassi 2014